EPCAM and carcinoma: EpCAM-based capture methods are inherently biased towards capturing CTCs with epithelial cell characteristics and are less effective in carcinomas with downregulated EpCAM expression, such as during epithelial-mesenchymal transition (EMT) [6,7].